Claim · 2023-11-21 · publication · Stated in source · Supported

Genentech's release of 21 November 2023 describes its "lab in a loop" as a cycle in which experimental data feed computational models whose testable predictions are assessed in the lab and fed back to improve the models.

One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.

What it connects

Genentech and NVIDIA Enter Into Strategic AI Research Collaboration → states provision → "lab in a loop" as Genentech describes it (2023)

Where it appears

No collection page holds this claim. It is listed with its records in the explorer.

Claim and evidence

Genentech and NVIDIA Enter Into Strategic AI Research Collaborationstates provision ↓"lab in a loop" as Genentech describes it (2023)

Machine-checked, not reviewed by an editorStated in sourceSupported

Supporting evidence: primary · 1 source

Provision: Statement · provision ID co-genentech-lab-in-a-loop-2023
Date: 2023-11-21 · publication Records dated 2023 →

Scope and limitsGenentech's description of its approach; it is not evidence of faster discovery. The 2023 release writes "lab in a loop"; Genentech's 2021 story writes "lab in the loop".

The evidence 02

primary sourceSupports the claim

Genentech and NVIDIA Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development

Genentech · 2023-11-21

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“The collaboration will also help accelerate Genentech’s “lab in a loop”, where extensive experimental data feeds computational models that uncover patterns and make new, experimentally testable predictions.”

Location in source seventh paragraph

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Genentech
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 34e7072e1c3903bdeb3e0242032f52a12c492a9c8d0de4d323a7783d456de743). gene.com press release page, dated Tuesday, Nov 21, 2023, as served on 2026-10-30. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Genentech, “Genentech and NVIDIA Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development”, 2023-11-21.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (27 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review.

primary sourceSupports the claim

Genentech and NVIDIA Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development

Genentech · 2023-11-21

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Paraphrase

the next sentence says that scientists assess these predictions in the lab and that the results are fed back into the models to improve the underlying computational model.

Location in source seventh paragraph, next sentence

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Genentech
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 34e7072e1c3903bdeb3e0242032f52a12c492a9c8d0de4d323a7783d456de743). gene.com press release page, dated Tuesday, Nov 21, 2023, as served on 2026-10-30. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Genentech, “Genentech and NVIDIA Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development”, 2023-11-21.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The paraphrase is Selekoa’s, written from the text retrieved for the candidate pack on 2026-10-30; it is not a quotation and was not machine-matched. Explicit paraphrase, to keep the release within its quotation budget. No human editorial review.

Status and meaning

Editorial status. Not reviewed by an editor. An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.

Relation. An exact framework edition, or another document with an exact expression, states one provision: a capability threshold or risk level and its trigger, a required safeguard or action, a decision authority (who decides, recommends, can overrule or is informed), a stated exception, or another statement of its content, such as a licence term or a prospectus statement. The passage records what the document says, not implementation, compliance or effectiveness. Provisions with the same key align across editions of one family.

Date. Date of the release. The record is dated by the text’s date of publication, which is the date of its announcement.

Record ID aib-co-genentech-lab-in-a-loop-2023